BR0208588A - Antìgenos para despertar uma resposta imune contra patógenos de ehrilichieae e rickettsieae - Google Patents

Antìgenos para despertar uma resposta imune contra patógenos de ehrilichieae e rickettsieae

Info

Publication number
BR0208588A
BR0208588A BR0208588-7A BR0208588A BR0208588A BR 0208588 A BR0208588 A BR 0208588A BR 0208588 A BR0208588 A BR 0208588A BR 0208588 A BR0208588 A BR 0208588A
Authority
BR
Brazil
Prior art keywords
rickettsieae
pathogens
immune response
response against
ehrilichieae
Prior art date
Application number
BR0208588-7A
Other languages
English (en)
Inventor
George Alfred Riding
Michelle Anne Hope
Peter Willadsen
Original Assignee
Queensland Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR4400A external-priority patent/AUPR440001A0/en
Priority claimed from AUPS0861A external-priority patent/AUPS086102A0/en
Application filed by Queensland Inst Med Res filed Critical Queensland Inst Med Res
Publication of BR0208588A publication Critical patent/BR0208588A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"ANTìGENOS PARA DESPERTAR UMA RESPOSTA IMUNE CONTRA PATóGENOS DE EHRLICHIEAE E RICKETTSIEAE". A presente invenção relaciona-se à identificação de polipeptídeos que são úteis para despertar uma resposta imune contra patógenos de Ehrlichieae e Rickettsieae quando administrados em um indivíduo. Portanto estes polipeptídeos, e polinucleotídeos que codificam, podem ser usados em várias estratégias para prevenir ou tratar infecções por Ehrlichieae e Rickettsieae.
BR0208588-7A 2001-04-12 2002-04-11 Antìgenos para despertar uma resposta imune contra patógenos de ehrilichieae e rickettsieae BR0208588A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPR4400A AUPR440001A0 (en) 2001-04-12 2001-04-12 Vaccine
AUPR759701 2001-09-10
AUPS0861A AUPS086102A0 (en) 2002-02-03 2002-02-03 Vaccine iii
PCT/AU2002/000468 WO2002083724A1 (en) 2001-04-12 2002-04-11 Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens

Publications (1)

Publication Number Publication Date
BR0208588A true BR0208588A (pt) 2004-03-23

Family

ID=27158285

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208588-7A BR0208588A (pt) 2001-04-12 2002-04-11 Antìgenos para despertar uma resposta imune contra patógenos de ehrilichieae e rickettsieae

Country Status (4)

Country Link
US (1) US20060088546A1 (pt)
BR (1) BR0208588A (pt)
MX (1) MXPA03009306A (pt)
WO (1) WO2002083724A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090297526A1 (en) * 2005-06-08 2009-12-03 Board Of Regents, The University Of Texas System Membranolytic Polypeptides and Methods of Use
WO2013113000A2 (en) 2012-01-26 2013-08-01 Luc Montagnier Detection of dna sequences as risk factors for hiv infection
CN114231513B (zh) * 2022-02-23 2022-05-10 中国人民解放军军事科学院军事医学研究院 一种可抑制蛋白酶体psmb5亚基活性的短肽及其在抗立克次体感染中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
GR860772B (en) * 1985-03-25 1986-07-21 Univ Washington Anaplasma marginale subunit antigen for vaccination and diagnosis
US5177010A (en) * 1986-06-30 1993-01-05 University Of Toledo Process for transforming corn and the products thereof
SE455438B (sv) * 1986-11-24 1988-07-11 Aga Ab Sett att senka en brennares flamtemperatur samt brennare med munstycken for oxygen resp brensle
US5004863B2 (en) * 1986-12-03 2000-10-17 Agracetus Genetic engineering of cotton plants and lines
US5141131A (en) * 1989-06-30 1992-08-25 Dowelanco Method and apparatus for the acceleration of a propellable matter
US5384253A (en) * 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
US5939400A (en) * 1996-02-26 1999-08-17 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for induction of suppressive T cell response
AU3210997A (en) * 1996-05-24 1997-12-09 University Of Maryland At Baltimore Dna vaccines for eliciting a mucosal immune response

Also Published As

Publication number Publication date
MXPA03009306A (es) 2004-11-12
US20060088546A1 (en) 2006-04-27
WO2002083724A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
BR0208142A (pt) Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona
BR0209254A (pt) anticorpos de bloqueio cripto e usos dos mesmos
BR9909472A (pt) Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
DE602004024542D1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
BR0007597A (pt) Composição hipoalergênica contendo peptìdios tolerogênicos induzindo tolerância oral
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
BR0306854A (pt) Gerenciador de integridade de integração
CY1112171T1 (el) Μτβ32α αντιγονο μυκοβακτηριδιου της φυματιωσης με απενεργοποιημενη δραστικη θεση και πρωτεϊνες συντηξης αυτου
UY27186A1 (es) Formulación farmacéutica
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
NO307495B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av Parkinsons sykdom og Parkinsonske syndromer
BRPI0412265A (pt) uso de calcitonina em osteoartrite
CY1108147T1 (el) Εμβολιο κατα των σεξουαλικως μεταδιδομενων νοσων
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
BR0201524A (pt) Tratamento de combinação para ansiedade e depressão
BR0006291A (pt) Bactéria do gênero salmonella, vacina para aproteção de animais contra a salmonelose, uso deuma bactéria, e, processo para a preparação deuma vacina
BR0009663A (pt) Composições de vacinas antibacterianas
BR0207018A (pt) Leptina modificada com imunogenicidade reduzida
BR0207015A (pt) Eritropoientina modificada (epo) com imunogenicidade reduzida
BR0208588A (pt) Antìgenos para despertar uma resposta imune contra patógenos de ehrilichieae e rickettsieae
TR201820975A2 (tr) İbuprofen, Psödoefedrin ve Erdostein İçeren Uzatılmış Salım Sağlayan Farmasötik Kompozisyon
BR0011469A (pt) Gm-csf equina

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR

Free format text: TRANSFERIDO DE: THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.